High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice

Journal of Hepatology

Volumn 37, Issue 5, 2002, Pages 620-624

  Turlin, Bruno ^a,b   Le Quilleuc, Danielle ^a   Leroyer, Patricia ^a   Brissot, Pierre ^a   Deugnier, Yves ^a   Loréal, Olivier ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Angiogenesis; Experimental pathology; Immunohistochemistry; Iron overload; Liver neoplasm; Mice; Preneoplastic lesion; Vascular endothelial growth factor (VEGF)

Indexed keywords

DIETHYLNITROSAMINE; EOSIN; HEMATOXYLIN; IRON DEXTRAN; VASCULOTROPIN; ALKYLATING AGENT; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C3H MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; IRON OVERLOAD; LIVER TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PRECANCER;

ALKYLATING AGENTS; ANIMALS; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON OVERLOAD; LIVER NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; PRECANCEROUS CONDITIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036845706     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00249-0     Document Type: Article

References (26)

1. Pitot HC, Sirica AE. The stage of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 1980:191-215.
2. Koen H, Pugh T, Goldfarb S. Hepatocarcinogenesis in the mouse. Combined morphologic-stereologic studies. Am J Pathol 1983; 112:89-100.
3. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990; 84:4-6.
4. Guidi A, Fisher L, Harris J, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994; 86:614-619.
5. Chow N, Hsu P, Lin X, Yang H, Chan S, Cheng K, et al. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: An immunohistochemical study. Hum Patrol 1997; 28:698-703.
6. Miura H, Miyazaki T, Kuroda M, Oka T, Machinami R, Kodama T, et al. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatol 1997; 27:854-861.
7. Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, et al. Clinical significance of vascular endothelial growth factor and basic fibroblastic growth factor gene expression in liver tumor. Hepatology 1996; 23:455-464.
8. El-Assal O, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998; 27:1554-1562.
9. Yamaguchi R, Yano H, Iemura A, Ogasawara S, Haramaki M, Kojiro M. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 1998; 28:68-77.
10. Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, et al. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol 1998; 29:986-991.
11. Park Y, Kim Y, Yang K, Park C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 2000; 124:1061-1065.
12. Qi An F, Matsuda M, Fujii H, Matsumoto Y. Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma. J Cancer Res Clin Oncol 2000; 126:153-160.
13. Zhou J, Tang Z, Fan J, Wu Z, Li X, Liu Y, et al. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol 2000; 126:57-61.
14. Vesselinovitch SD, Hacker HJ, Bannasch P. Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice. Cancer Res 1985; 45:2774-2780.
15. Hirota N, Williams G. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am J Pathol 1979; 95:317-328.
16. Williams G, Yamamoto R. Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis. J Natl Cancer Inst 1972; 49:685-692.
17. Smith A, Francis J. Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice. Biochem J 1983; 214:909-913.
18. Deugnier Y, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102:2050-2059.
19. Deugnier Y, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, et al. Preneoplastic significance of hepatic iron-free-foci in genetic hemochromatosis: A study of 185 patients. Hepatology 1993; 18:1363-1369.
20. Jones TC, Popp JA, Mohr U. Monographs on Pathology of Laboratory Animals. Digestive System, 2nd Ed., Berlin: Springer, 1997. p. 457.
21. Ward J, Goodman D, Squire R, Chu K, Linhart M. Neoplastic and non-neoplastic lesions in aging (C57BL/6N X C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst 1979; 63:849-854.
22. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty changes in small hepatocellular carcinoma of humans. J Hepatol 2000:282-289.
23. Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 1999; 19:287-296.
24. Shweiki D, Itin A, Softer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845.
25. Wiesener MS, Munchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas. Cancer Res 2001; 61:5215-5222.
26. Musso O, Théret N, Campion J, Turlin B, Milani S, Grappone C, et al. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. J Hepatol 1997; 26:593-605.